What to know before choosing Willow
Willow's $299 entry point is an all-in program figure for eligible semaglutide patients, not just a platform fee. That makes it easier to compare with programs that split membership and medication. It still remains a starting amount because dose, prescription, and route can affect the charge.
The oral catalog deserves careful discussion. Willow publishes needle-free semaglutide and tirzepatide pages, but compounded oral formulations are not interchangeable with approved injectable products. Patients should ask about the clinical rationale, absorption uncertainty, dosing instructions, and alternatives.
Automatic renewal and pharmacy processing shape the refund risk. A cancellation after the cutoff may apply only to a later cycle, and public documents use slightly different definitions of the required notice. Sending an early written request is the safest practical approach.
- Programs start at $299 for semaglutide and $399 for tirzepatide, with care and shipping included.
- Willow offers both injectable and oral compounded GLP-1 routes, subject to clinical approval.
- Submit cancellation more than two business days before processing because public cutoff language differs.
